<DOC>
	<DOCNO>NCT01317992</DOCNO>
	<brief_summary>The purpose study determine ibudilast effective reverting patient medication overuse headache suffer chronic daily headache back original episodic headache pattern .</brief_summary>
	<brief_title>Ibudilast Treatment Medication Overuse Headache</brief_title>
	<detailed_description>It establish excessive intake medication use treat primary headache , particularly contain opioids , induce form secondary headache , know medication overuse headache ( MOH ) . Despite significant clinical impact condition mechanism behind MOH remain poorly understood , guideline treatment lacking , relapse common . Recently , recognise repeat opioid exposure facilitate pain activate glia , immunocompetent cell central nervous system , result opioid-induced hyperalgesia ( OIH ) . The investigator hypothesise MOH represent form OIH susceptible patient group - repeat activation nociceptive pathway frequent headache interacts opioid induce pro-inflammatory action activate glia produce chronic daily headache ( CDH ) . This double-blind , randomise , placebo control pilot study investigate use ibudilast , know attenuator glial activation , treatment medication overuse headache .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Headache Disorders , Secondary</mesh_term>
	<mesh_term>Ibudilast</mesh_term>
	<criteria>Inclusion criterion : Regular use , least 3 month , opioidcontaining analgesic ≥ 10 days/month Headache present least 15 days/month , least 2 month Headache develop markedly worsen medication overuse Primary indication analgesic headache disorder Exclusion criterion : Unable provide write informed consent Age &lt; 18 year time screen Unable read write English Receiving tramadol regularly Taking triptans &gt; 4 days/month Taking opioids reason headache ( e.g . pain condition , cough , bowel motility ) Severe psychiatric disorder Other chronic pain condition likely interfere qualitative sensory testing ( e.g . trigeminal neuralgia , arthritis ) Diabetic neuropathy Recent current active infection , determine clinically significant Principal investigator Known active inflammatory disease rheumatoid arthritis History cerebrovascular disorder Recent history significant trauma , determine Principal Investigator include major surgery within previous 2 month Recent history drug alcohol abuse Spinal cord injury Any clinically significant finding screen blood sample result Current malignancy Known hypersensitivity ibudilast excipients Pinatos® formulation Renal hepatic impairment , define baseline GFR ( calculate CockcroftGault equation ) &lt; 60 mL/min LFTs &gt; 3 time upper limit normal For female childbearing potential : Pregnancy Lack adequate contraception ( abstinence , double barrier method , intrauterine device , surgical sterilization ( self partner ) , hormonal contraceptive method ( oral , injected , implant ) Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Medication overuse headache</keyword>
	<keyword>ibudilast</keyword>
	<keyword>glia</keyword>
</DOC>